Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.

NCT06571669 is registered in ClinicalTrials.gov with Boomerang Medical as lead sponsor.

NCT NCT06571669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06571669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.
Lead sponsor
Boomerang Medical
Phase
Not applicable
Overall status
Recruiting
Start date
January 31, 2025
Completion date
November 30, 2027
Enrollment
137 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases, ulcerative colitis